Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Sarah M. Sharkey"'
Publikováno v:
Vaccine. 40:7187-7190
In 2018, CDC recommended a highly efficacious adjuvanted recombinant zoster vaccine (RZV) as a 2-dose series for prevention of herpes zoster (HZ) for immunocompetent persons age ≥ 50 years, with the 2nd dose recommended 2-6 months after the 1st dos